OncoAlert Colloquium Day 3: Breast cancer

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma

OncoAlert Colloquium Day 5: Genitourinary tumours and social media

Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML

Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients

Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel

Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients

A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib

2020 updates in treating NTRK fusion cancer

PARP inhibitors for prostate cancer: What oncology PAs should know

ESMO 2020: New developments in the treatment of lung cancer

SABCS 2020: Conference roundup